Naltrexone in AUD Reward Drinkers — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Naltrexone in AUD Reward Drinkers — Stella

Home/Alcohol Use Disorder/

View on ClinicalTrials.gov

Recruiting

Back to Alcohol Use Disorder trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

University of Pennsylvania Center for Studies of Addiction, Philadelphia, Pennsylvania

Key details

Phase

Post-approval study

Sponsor

University of Pennsylvania

Collaborators

Alkermes, Inc.

Enrollment target

~60 participants

Started

March 2022

Primary completion

July 2027

Age range

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

18 Years – 65 Years

Last updated January 2026